PillEye – tablet, pill counter

by Medility
500,000+ installs

Android application PillEye – tablet, pill counter developed by is listed under category Medical. According to Google Play PillEye – tablet, pill counter achieved more than 500,000 installs. PillEye – tablet, pill counter currently has 1,632 ratings with average rating value of 3.68. The current percentage of ratings achieved in last 30 days is 0.63%, percentage of ratings achieved in last 60 days is 1.65%. PillEye – tablet, pill counter has the current market position #97370 by number of ratings. A sample of the market history data for PillEye – tablet, pill counter can be found below. Last update on 2026-06-11.

Android application info
Title:PillEye – tablet, pill counter
Developer:
Category:Medical
Price:Free
System:Android
Rating scores
Total ratings:1632
Growth (30 days):0.63%
Growth (60 days):1.65%
Average rating:3.68
App installs
Installs (achieved):500,000+
Installs (estimated):536,136
Rating values
5 star ratings:846
4 star ratings:179
3 star ratings:211
2 star ratings:32
1 star ratings:358

Screenshots

screenshot of PillEye – tablet, pill counterscreenshot of PillEye – tablet, pill counterscreenshot of PillEye – tablet, pill counterscreenshot of PillEye – tablet, pill counterscreenshot of PillEye – tablet, pill counter

Download level stats
2025-09-02: Android application PillEye – tablet, pill counter achieved 500,000 installs.
2022-02-02: Android application PillEye – tablet, pill counter achieved 100,000 installs.
2021-09-15: Android application PillEye – tablet, pill counter achieved 50,000 installs.
2021-01-16: Android application PillEye – tablet, pill counter achieved 10,000 installs.

Ratings
Number of ratings for PillEye – tablet, pill counter.

Installs (*estimated)
Estimated number of installs on Google Play.

Average rating
Average rating value on Google Play. Given by active users of the application.

Market lead percentage
Ratings count comparing to the market leading app.

Rating distribution
Rating distribution given by active users.